Endovascular Treatment for Medium and Distal Vessel Occlusion Stroke: Are We Missing the Point?
In our study, conducted at 2 centers participating in DMVO clinical trials, randomized patients presented milder clinical severity and smaller hypoperfusion areas compared with those treated in daily practice, suggesting a potential selection bias. Our findings highlight the importance of consecutive recruitment in future DMVO trials to clarify the role of EVT.
Authors
- N. Abdelhakim (ORCID: https://orcid.org/0000-0003-4497-984X)
- Federica Rizzo (ORCID: https://orcid.org/0000-0002-5945-8222)
- Renato Simonetti (ORCID: https://orcid.org/0009-0007-1480-6610)
- Marta de Dios Lascuevas (ORCID: https://orcid.org/0000-0002-3606-4212)
- Manuel Requena
- Jorge Cespedes (ORCID: https://orcid.org/0000-0001-9826-7077)
- Eric Kontowicz (ORCID: https://orcid.org/0000-0003-1323-4925)
- William D. Haselden (ORCID: https://orcid.org/0000-0001-6542-7505)
- A Tomasello
- Jordi Mayol (ORCID: https://orcid.org/0009-0005-9289-4658)
- Leonardo Cruz-Criollo
- Francesco Diana
- Marta Olivé-Gadea
- Marc Rodrigo-Gisbert
- Alvaro García-Tornel
- Mario Zanaty
- Santiago Ortega-Gutierrez
- Marc Ribo
- David Hernandez
- Ane Murillo-Olaizola
- Anderson Brito-Alvarado
Institutions
- University of Iowa (US)
- Anna Needs Neuroblastoma Answers (US)
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- Stroke Vascular and Interventional Neurology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1161/svin.125.002137
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00